Anja J. Stauber

1.3k citations

13 papers · 1.0k indexed · 1 hit paper · h-index 12

Co-authors: J. Christopher Corton Steven P. Anderson Michael Lahn Ivelina Gueorguieva Ann Cleverly Christopher A. Slapak Kyla Driscoll Shawn T. Estrem
Topics: Peroxisome Proliferator-Activated Receptors (5 papers)Pancreatic and Hepatic Oncology Research (3 papers)TGF-β signaling in diseases (3 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Pharmacology and Experimental Therapeutics The Annual Review of Pharmacology and Toxicology Molecular Pharmacology
Partner nations: United States Germany United Kingdom

In The Last Decade

Anja J. Stauber

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

2015 453 citations Michael Lahn, Stephan Herbertz et al. Drug Design Development and Therapy profile →

Peers

Countries citing papers authored by Anja J. Stauber

Since Specialization

Citations

This map shows the geographic impact of Anja J. Stauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja J. Stauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja J. Stauber more than expected).

Fields of papers citing papers by Anja J. Stauber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja J. Stauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja J. Stauber. The network helps show where Anja J. Stauber may publish in the future.

Co-authorship network of co-authors of Anja J. Stauber

This figure shows the co-authorship network connecting the top 25 collaborators of Anja J. Stauber. A scholar is included among the top collaborators of Anja J. Stauber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja J. Stauber. Anja J. Stauber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	RECOVER-E – a mobile app for patients undergoing total knee or hip replacement: study protocol 2020 ·BMC Musculoskeletal Disorders ·Anja J. Stauber,Nadine Schüßler,(unknown),(unknown),David E. Bruns,Jürgen Osterbrink,Nadja Nestler	16
2	TGF‐β1 monoclonal antibody: Assessment of embryo‐fetal toxicity in rats and rabbits 2016 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·(unknown),Jennifer A. Martin,Anja J. Stauber,(unknown),William J. Breslin	3
3	Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathwaybreakdown → 2015 ·Drug Design Development and Therapy ·Michael Lahn,Stephan Herbertz,(unknown),Anja J. Stauber,Ivelina Gueorguieva,Kyla Driscoll,Shawn T. Estrem,Ann Cleverly,(unknown),Susan C. Guba,Karim A. Benhadji,Christopher A. Slapak	453
4	Generation and Activity of a Humanized Monoclonal Antibody That Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands Transforming Growth Factor-α and Epiregulin 2014 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Ramona J. Petrovan,Elaine M. Conner,(unknown),Derek Yang,Shannon M. Harlan,Shaoyou Chu,Bernice Ellis,Amita Datta‐Mannan,Robert L. Johnson,Anja J. Stauber,Derrick R. Witcher,Matthew D. Breyer,Josef G. Heuer	13
5	Defining a therapeutic window for the novel TGF‐β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model 2013 ·British Journal of Clinical Pharmacology ·Ivelina Gueorguieva,Ann Cleverly,Anja J. Stauber,Nischalan Pillay,Jordi Rodón,Colin Miles,Jonathan M. Yingling,Michael Lahn	66
6	Nonclinical Aspects of Biopharmaceutical Development: Discussion of Case Studies at a PhRMA-FDA Workshop 2008 ·International Journal of Toxicology ·Lorrene A. Buckley,(unknown),Karen Davis‐Bruno,(unknown),Gregory L. Finch,Patricia Harlow,Helen G. Haggerty,T K Hart,Lewis B. Kinter,John K. Leighton,John McNulty,Lorin Roskos,Haleh Saber,Anja J. Stauber,Mohammad Tabrizi	12
7	Activation of Peroxisome Proliferator–Activated Receptor Alpha Enhances Apoptosis in the Mouse Liver 2006 ·Toxicological Sciences ·Shen Xiao,Steven P. Anderson,Cynthia Swanson,(unknown),Kenneth A. Voss,Anja J. Stauber,J. Christopher Corton	21
8	Constitutive Expression of Peroxisome Proliferator-Activated Receptor α-Regulated Genes in Dwarf Mice 2004 ·Molecular Pharmacology ·Anja J. Stauber,Holly M. Brown‐Borg,Jie Liu,Michael P. Waalkes,(unknown),(unknown),(unknown),Cynthia Swanson,Kenneth A. Voss,John J. Kopchick,J. Christopher Corton	36
9	Contribution of Dichloroacetate and Trichloroacetate to Liver Tumor Induction in Mice by Trichloroethylene 2002 ·Toxicology and Applied Pharmacology ·Richard J. Bull,Gayle A. Orner,Rita Cheng,Lisa C. Stillwell,Anja J. Stauber,L. B. Sasser,Melissa K. Lingohr,Brian D. Thrall	58
10	Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice 2001 ·Journal of Applied Toxicology ·(unknown),Anja J. Stauber,Gayle A. Orner,Brian D. Thrall,Richard J. Bull	14
11	Central Role of Peroxisome Proliferator–Activated Receptors in the Actions of Peroxisome Proliferators 2000 ·The Annual Review of Pharmacology and Toxicology ·J. Christopher Corton,Steven P. Anderson,Anja J. Stauber	278
12	Dichloroacetate and Trichloroacetate Promote Clonal Expansion of Anchorage-Independent Hepatocytesin Vivoandin Vitro 1998 ·Toxicology and Applied Pharmacology ·Anja J. Stauber,Richard J. Bull,Brian D. Thrall	18
13	Differences in Phenotype and Cell Replicative Behavior of Hepatic Tumors Induced by Dichloroacetate (DCA) and Trichloroacetate (TCA) 1997 ·Toxicology and Applied Pharmacology ·Anja J. Stauber,Richard J. Bull	37

About Anja J. Stauber

Anja J. Stauber is a scholar working on Oncology, Pathology and Forensic Medicine and Health, Toxicology and Mutagenesis, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and TGF-β signaling in diseases (3 papers). The work is most often cited by research in Cancer Research (207 citations), Oncology (375 citations) and Molecular Biology (612 citations). Anja J. Stauber has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include J. Christopher Corton, Steven P. Anderson, Michael Lahn, Ivelina Gueorguieva, Ann Cleverly, Christopher A. Slapak, Kyla Driscoll, Shawn T. Estrem, Susan C. Guba and Karim A. Benhadji. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, The Annual Review of Pharmacology and Toxicology and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact